Compared with the Western region, hospitals in central regions of Inner Mongolia were less likely to give T2DM inpatients oral therapy (RRR = 0.18) and insulin therapy (RRR = 0.20) than lifestyle management. This evidence concerns the gene INS and type 2 diabetes mellitus.